SAB BIOTHERAPEUTICS INC (SABS) Stock Earnings & Estimates
USA - NASDAQ:SABS - US78397T2024 - Common Stock
3.18 USD
-0.07 (-2.15%)
3.18 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 23.904M -60.73% | 2.239M -90.63% | 1.322M -40.94% | -100.00% | 7.691M | 87.828M 1,041.96% | 228.58M 160.26% | 355.47M 55.51% | 557.94M 56.96% | |||
| EBITDA YoY % growth | -25.627M -115.26% | -34.322M -33.93% | -38.018M -10.77% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -28.796M -114.99% | -37.975M -31.88% | -42.811M -12.73% | -44.438M -3.80% | -56.363M -26.84% | -71.477M -26.82% | -78.544M -9.89% | -80.294M -2.23% | -6.243M 92.22% | -111.18M -1,680.90% | -25.5M 77.06% | |
| Operating Margin | -120.47% | -1,696.07% | -3,237.33% | N/A | N/A | N/A | -1,021.24% | -91.42% | -2.73% | -31.28% | -4.57% | |
| EPS YoY % growth | -2.70 -37.51% | -7.28 -169.63% | -3.74 48.68% | -2.31 38.16% | -1.18 49.05% | -0.44 62.22% | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.52 53.92% | -0.51 58.40% | -0.57 -1.09% | -0.58 46.66% | -0.57 -9.68% | -0.57 -12.00% | -0.06 89.19% | -0.07 87.72% | -0.06 89.19% | -0.06 89.29% |
| Revenue Q2Q % growth | -100.00% | |||||||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -11.252M -0.12% | -12.274M -22.63% | -11.399M -6.47% | -11.883M -22.92% | -12.368M -9.91% | -12.852M -4.71% | -16.065M -40.94% | -16.83M -41.63% | -17.595M -42.27% | -18.36M -42.86% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -1.09 -37.97% | -0.81 | -0.28 | -34.25% |
| Q1 2025 Q2Q % growth | -0.56 6.67% | -1.05 | 0.49 | 46.70% |
| Q4 2024 Q2Q % growth | -1.23 63.73% | -1.19 | -0.04 | -3.26% |
| Q3 2024 Q2Q % growth | -1.12 -12.00% | -1.11 | -0.01 | -0.74% |
| Q2 2024 Q2Q % growth | -0.79 43.57% | -1.15 | 0.36 | 31.46% |
| Q1 2024 Q2Q % growth | -0.60 60.00% | -0.98 | 0.38 | 38.73% |
| Q4 2023 Q2Q % growth | -3.38 -1,590.00% | -0.63 | -2.75 | -434.47% |
| Q3 2023 Q2Q % growth | -1.00 37.50% | -1.19 | 0.19 | 15.97% |
| Q2 2023 Q2Q % growth | -1.40 -27.27% | -1.48 | 0.08 | 5.34% |
| Q1 2023 Q2Q % growth | -1.50 -850.00% | -0.82 | -0.68 | -83.82% |
| Q4 2022 Q2Q % growth | -0.20 96.97% | -0.36 | 0.16 | 43.98% |
| Q3 2022 Q2Q % growth | -1.60 -700.00% | -1.63 | 0.03 | 1.96% |
| Q2 2022 Q2Q % growth | -1.10 | -1.73 | 0.63 | 36.56% |
| Q1 2022 Q2Q % growth | 0.20 | -1.68 | 1.88 | 111.88% |
| Q4 2021 Q2Q % growth | -6.60 | -1.12 | -5.48 | -488.24% |
| Q3 2021 Q2Q % growth | -0.20 | -0.88 | 0.68 | 77.38% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -100.00% | % | ||
| Q1 2025 Q2Q % growth | -100.00% | 255K | -255K | -100.00% |
| Q4 2024 Q2Q % growth | 114.7K -62.39% | 122.4K | -7.7K | -6.29% |
| Q3 2024 Q2Q % growth | -100.00% | 153K | -153K | -100.00% |
| Q2 2024 Q2Q % growth | 263K 207.53% | 263K | % | |
| Q1 2024 Q2Q % growth | 944K 62.45% | 944K | % | |
| Q4 2023 Q2Q % growth | 305K -85.89% | 305K | % | |
| Q3 2023 Q2Q % growth | 1.267M -64.71% | 20.4K | 1.247M | 6,110.78% |
| Q2 2023 Q2Q % growth | 85.52K -98.65% | 414.803K | -329.283K | -79.38% |
| Q1 2023 Q2Q % growth | 581.1K -95.08% | 2.406M | -1.825M | -75.85% |
| Q4 2022 Q2Q % growth | 2.161M -96.45% | 6.634M | -4.473M | -67.43% |
| Q3 2022 Q2Q % growth | 3.59M | 6.987M | -3.397M | -48.62% |
| Q2 2022 Q2Q % growth | 6.351M | 11.016M | -4.665M | -42.35% |
| Q1 2022 Q2Q % growth | 11.803M | 11.696M | 107K | 0.91% |
| Q4 2021 Q2Q % growth | 60.876M | 15.3M | 45.576M | 297.88% |
| Q3 2021 Q2Q % growth | 17.238M | -17.238M | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -1.61% | 0% | -11.14% |
| Revenue | N/A | N/A | N/A | N/A |